Zhejiang Jingxin Pharmaceutical Achieves H1 2025 Net Profits of RMB 388 Million, Down 3.54% Year-on-Year
Continue reading with Effamall membership.
Already a member? Login here.
Tag:
Copy Link
<Prev
Next>
<Prev
Next>
